PETALUMA, Calif.–(BUSINESS WIRE)—- $QTI #BreastCancer–QT Imaging Holdings, Inc. (Nasdaq: QTI) (“QT Imaging” or the “Company”), a medical device company dedicated to transforming breast health management through innovative, radiation-free imaging technology, today announced that the Centers for Medicare & Medicaid Services (CMS) has established a separately payable Medicare hospital outpatient classification for diagnostic QTscan® examinations, effective January 1, 2027. CMS recognized that QTscan diagnostic s

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.